MedPath

ENSO-16

Generic Name
ENSO-16

ENSO 16 - Study in Healthy Subjects

Phase 1
Completed
Conditions
Sugar; Blood, Low
Interventions
Drug: Glucose Powder
First Posted Date
2022-07-14
Last Posted Date
2023-02-21
Lead Sponsor
Alpha Republic GmbH
Target Recruit Count
15
Registration Number
NCT05457400
Locations
🇦🇹

Universitätsklinik für Klinische Pharmakologie,, Vienna, Austria

© Copyright 2025. All Rights Reserved by MedPath